GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Synthetic organic
Comment: PF-07258669's chemical structure was revealed during the first disclosures session at the 2022 ACS meeting in Chicago. This is Pfizer's melanocortin 4 receptor (MC4R) antagonist. Blocking MC4R activation is proposed as a mechanism to increase weight gain, and Pfizer intend this agent to be used to treat geriatric anorexia.
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| (2R)-2-(5-fluoro-2-methoxypyridin-4-yl)-1-[(2S)-7-methyl-6-(pyrimidin-2-yl)-3,4-dihydro-1H-spiro[1,8-naphthyridine-2,3'-pyrrolidin]-1'-yl]propan-1-one |
Database Links ![]() |
|
| GtoPdb PubChem SID | 472319280 |
| PubChem CID | 164889476 |
| Search Google for chemical match using the InChIKey | PARGFYLSRQUWHR-BZQUYTCOSA-N |
| Search Google for chemicals with the same backbone | PARGFYLSRQUWHR |
| UniChem Compound Search for chemical match using the InChIKey | PARGFYLSRQUWHR-BZQUYTCOSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | PARGFYLSRQUWHR-BZQUYTCOSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖|
PF-07258669 (links to external site)
Cat. No. HY-148349 |